Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 39, 2011, Pages 16369-16374

  Wong, Carmen Chak Lui ^a   Gilkes, Daniele M ^a   Zhang, Huafeng ^a,b   Chen, Jasper ^a   Wei, Hong ^a   Chaturvedi, Pallavi ^a   Fraley, Stephanie I ^c   Wong, Chun Ming ^d,e   Khoo, Ui Soon ^e   Ng, Irene Oi Lin ^d,e   Wirtz, Denis ^c   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c Johns Hopkins University   (United States)

^d THE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Extracellular matrix; Lung metastasis

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN LYSINE 6 OXIDASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER GROWTH; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGEN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASM METASTASIS;

MUS;

EID: 80053645045     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113483108     Document Type: Article

References (18)

1. Vaupel P, Mayer A, Höckel M (2004) Tumor hypoxia and malignant progression. Methods Enzymol 381:335-354. (Pubitemid 38401518)
2. Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625-634.
3. 2 tension. Proc Natl Acad Sci USA 92:5510-5514.
4. Chintala S, et al. (2010) Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α. Cancer Chemother Pharmacol 66:899-911.
5. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559-1564.
6. Kaplan RN, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827. (Pubitemid 41753060)
7. Erler JT, et al. (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15:35-44.
8. Erler JT, et al. (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222-1226.
9. Csiszar K (2001) Lysyl oxidases: A novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 70:1-32.
10. Levental KR, et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891-906.
11. Schietke R, et al. (2010) The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: Insights into cellular transformation processes mediated by HIF-1. J Biol Chem 285:6658-6669.
12. Semenza GL, et al. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537.
13. Bos R, et al. (2003) Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97:1573-1581. (Pubitemid 36297788)
14. Bondareva A, et al. (2009) The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS ONE 4:e5620.
15. Payne SL, Hendrix MJ, Kirschmann DA (2007) Paradoxical roles for lysyl oxidases in cancer - A prospect. J Cell Biochem 101:1338-1354. (Pubitemid 47242767)
16. Görögh T, et al. (2007) Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma. J Pathol 212:74-82. (Pubitemid 46746292)
17. Kim Y, et al. (2009) Differential expression of the LOX family genes in human colorectal adenocarcinomas. Oncol Rep 22:799-804.
18. Barry-Hamilton V, et al. (2010) Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 16:1009-1017.